EVALUATION OF ANTIDEPRESSANT ACTIVITY OF CRINUM LATIFOLIUM EXTRACT ON EXPERIMENTAL ANIMALS
Dr. DV Kishore*, Shabana Begum, Dr. Shaik Mohd Khasim, Dr. Sridhar Baburao
Abstract
Depression is among the most widespread critical conditions that
requires immediate attention. However, numerous depressive episodes
remain unnoticed. Patients with depression had a higher level of
cognitive impairment than people with chronic health conditions
including hypertension, diabetes, arthritis, or coronary artery
disease.The depression may be caused by a decreased levels or
dysfunctioning of monoaminergic transmitters, serotonin (5-HT),
norepinephrine (NE), and dopamine (DA). In the present study the
evaluation of antidepressant activity of Crinum latifolium on
experimental animals is carried out. Mice were treated with methanolic extract of C.
latifolium (MECL) at a doses (200mg/kg and 400mg/kg) and Imipramine (15mg/kg) as
standard drug and signs of behavioral, neurological toxicity, and mortality were observed.
The immobility time in FST and TST models were noted and compared with the standard
imipramine. C. latifolium extract showed dose-dependent decrease in immobility time. Even
though the mode of action of this extract is obscure, it is believed to be due to inhibition of
the norepinephrine transporter as well as the serotonin transporter, enhancing their
accessibility in the synaptic gap. It can be concluded that C.latifolium shows optimum
antidepressant activity at a dose of 400mg/kg body weight.
Keywords: Depression, Crinum latifolium, Forced swim test, Tail suspension test, antidepressant activity.
[Full Text Article]